The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis.

BACKGROUND The prognosis for brain metastasis is poor, and surgical resection is part of the standard of care for these patients as it has been shown to improve median overall survival. Development of neurological deficits after surgical resection has been associated with worsened outcomes in patients with glioblastoma. The effect of postoperative neurological deficits on survival in patients with single brain metastasis has not been studied to date. OBJECTIVE To evaluate the association between postoperative neurological deficits and median overall survival. METHODS A single-institution retrospective cohort study was performed on all patients with single brain metastasis undergoing surgical resection by a single neurosurgeon. RESULTS A total of 121 patients met the inclusion criteria for this study. Among them 61% of patients presented with a preoperative deficit, and 26% of patients had a new postoperative deficit. However, most postoperative deficits resolved and only 3.3% of patients developed a new permanent postoperative deficit. Median overall survival in patients with a new postoperative deficit was 2.4 mo, whereas mOS in patients without a postoperative deficit was 12.6 mo (P < .0001). CONCLUSION This study suggests that a new neurological deficit is associated with worsened outcomes after surgical resection of a single brain metastasis. This finding has potential implications for patient selection and counseling as the patients most likely to benefit from surgical resection are the patients who are most likely to have resolution of a preoperative deficit.

[1]  G. Tortora,et al.  Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives , 2020, Cancers.

[2]  R. Amaria,et al.  Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD‐1 in patients with metastatic melanoma , 2019, Cancer.

[3]  Timothy K. Nguyen,et al.  Predictors of Leptomeningeal Disease Following Hypofractionated Stereotactic Radiotherapy for Intact and Resected Brain Metastases. , 2019, Neuro-oncology.

[4]  B. Han,et al.  Management of Central Nervous System Metastases in Patients With Advanced Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer During Crizotinib Treatment. , 2019, Clinical lung cancer.

[5]  Hongwei Guo,et al.  Anaplastic lymphoma kinase inhibitors in non-small cell lung cancer patients with brain metastases: a meta-analysis. , 2019, Journal of thoracic disease.

[6]  J. Olson,et al.  Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors , 2019, Neurosurgery.

[7]  M. Suarez‐Almazor,et al.  Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group , 2017, Journal of Immunotherapy for Cancer.

[8]  Eudocia Q Lee,et al.  Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study , 2017, Neuro-oncology.

[9]  J. Buckner,et al.  Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. , 2017, The Lancet. Oncology.

[10]  F. Bova,et al.  The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. , 2017, Journal of neurosurgery.

[11]  G. Long,et al.  Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies. , 2017, European journal of cancer.

[12]  Volker W Stieber,et al.  Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. , 2016, JAMA.

[13]  E. Kekilli,et al.  Survival and prognostic factors in patients with brain metastasis: Single center experience. , 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[14]  P. Nakaji,et al.  The Current and Future Treatment of Brain Metastases , 2016, Front. Surg..

[15]  Yan Yuan,et al.  Canadian brain cancer survival rates by tumour type and region: 1992–2008 , 2016, Canadian Journal of Public Health.

[16]  Walter F. Wiggins,et al.  A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence. , 2014, International journal of radiation oncology, biology, physics.

[17]  B. Meyer,et al.  Postoperative ischemic changes following brain metastasis resection as measured by diffusion-weighted magnetic resonance imaging. , 2013, Journal of neurosurgery.

[18]  K. Stelzer,et al.  Epidemiology and prognosis of brain metastases , 2013, Surgical neurology international.

[19]  Steven D Chang,et al.  Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. , 2012, International journal of radiation oncology, biology, physics.

[20]  J. Joo,et al.  Incidence and Risk Factors for Leptomeningeal Carcinomatosis in Breast Cancer Patients with Parenchymal Brain Metastases , 2012, Journal of Korean Neurosurgical Society.

[21]  M. Smyth,et al.  Characterization of the supplementary motor area syndrome and seizure outcome after medial frontal lobe resections in pediatric epilepsy surgery. , 2012, Neurosurgery.

[22]  A. Olivi,et al.  Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. , 2011, Journal of neurosurgery.

[23]  Alfredo Quinones-Hinojosa,et al.  ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME , 2009, Neurosurgery.

[24]  Akash J. Patel,et al.  COMPARATIVE RISK OF LEPTOMENINGEAL DISSEMINATION OF CANCER AFTER SURGERY OR STEREOTACTIC RADIOSURGERY FOR A SINGLE SUPRATENTORIAL SOLID TUMOR METASTASIS , 2009, Neurosurgery.

[25]  Akash J. Patel,et al.  Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. , 2008, Journal of neurosurgery.

[26]  A. Young,et al.  Recursive Partitioning Analysis Classifications I and II: Applicability Evaluated in a Randomized Trial for Resected Single Brain Metastases , 2004, American journal of clinical oncology.

[27]  Jill S Barnholtz-Sloan,et al.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Gilsbach,et al.  Prognostic Factors for Patients with Microsurgically Resected Brain Metastases , 2002, Oncology Research and Treatment.

[29]  A. Twijnstra,et al.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.

[30]  G. Schackert,et al.  Surgical Management of Single and Multiple Brain Metastases: Results of a Retrospective Study , 2001, Oncology Research and Treatment.

[31]  W. Hall,et al.  Long-term survival with metastatic cancer to the brain , 2000, Medical oncology.

[32]  P. Levendag,et al.  Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. , 1999, International journal of radiation oncology, biology, physics.

[33]  M. J. van den Bent,et al.  Leptomeningeal metastasis after surgical resection of brain metastases , 1999, Journal of neurology, neurosurgery, and psychiatry.

[34]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[35]  L. K. Norris,et al.  Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: A potentially preventable complication , 1997, Journal of Neuro-Oncology.

[36]  G. Duncan,et al.  A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis , 1996, Cancer.

[37]  Ronald Brand,et al.  Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery , 1993, Annals of neurology.

[38]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[39]  G. Krol,et al.  Distribution of brain metastases. , 1988, Archives of neurology.

[40]  Y. Kluger,et al.  Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  K. Thomas,et al.  Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy. , 2017, The Ochsner journal.

[42]  U. Nestle,et al.  Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? , 2000, International journal of radiation oncology, biology, physics.

[43]  W Curran,et al.  Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. , 2000, International journal of radiation oncology, biology, physics.